PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Cetuximab modified collagen scaffold directs neurogenesis of injury-activated endogenous neural stem cells for acute spinal cord injury repair.

Mixed / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28544974 ↗2017Reported benefit

Cetuximab modified collagen scaffold directs neurogenesis of injury-activated endogenous neural stem cells for acute spinal cord injury repair.

MixedSpinal cord injuryUnspecifiedSprague-Dawley for the rat studies; dog strain not statedFemaleImplantation into the spinal cord lesion siteAcute phase after complete spinal cord injury

Model: Severe spinal cord injury in rats and acute complete spinal cord injury in dogs

Cetuximab significantly increased neurogenesis at the lesion site in rats, and cetuximab-modified scaffold implantation in dogs produced neuronal regeneration with myelination and synapse formation, reduced chondroitin sulfate proteoglycan deposition and significant locomotor recovery.

Extraction: extract · Supplied extraction confidence: 0.68. Machine-extracted fields require source verification.